Young and professional scientists, patients & patient representatives, and other rare diseases stakeholders are welcome to discuss latest cutting-edge research, innovation, and policy with the rare disease leaders.
The scientific program -inspired by IRDiRC principles, achievements, and activities foreseen in 2020- encompasses topics like diagnosis & artificial intelligence, molecular etiology, innovative clinical trials, patient engagement and drugs for all.
Blackswan Foundation and IRDiRC in collaboration with EJP RD organize this exceptional joint edition.
- innovation | research policy | medical research
- Berlin, Germany
- Live streaming available
- External event